Researchers at Gothenburg University have developed a reference method for standardized measurements that diagnose Alzheimer’s disease decades before symptoms appear. The method has now formally been classified as the international reference method, which means that it will be used as the standard in Alzheimer’s diagnostics worldwide.
Everyone naturally builds the beta amyloid protein in his or her brain. The protein’s normal function is not completely mapped, but one theory is that it participates in the formation and removal of synapses, which is vital in enabling the brain to form new memories.
Remain in the brain
Beta amyloid built by healthy people is quickly transported out to the spinal fluid and blood. But with Alzheimer’s, the beta amyloids remain in the brain, where they clump together and begin to damage the synapses, which leads to brain, nerve cell death.
This process can begin in middle age and continue unnoticed for decades until the nerve cells are so damaged that symptoms take the form of a memory disorder and impaired cognitive abilities. At that point, the disease is felt to be too advanced to be treated, so intensive worldwide research is underway to find methods that diagnose Alzheimer’s sooner.
After decades of research, Henrik Zetterberg and Kaj Blennow at Sahlgrenska Academy, Gothenburg University, were able to develop a method that measures the exact amount of beta amyloid in spinal fluid and diagnose Alzheimer’s ten to thirty years before the disease becomes symptomatic.
“If the concentration of beta amyloid in the spinal fluid is abnormally low, it indicates that the protein is sticking in the brain, which is the earliest sign of Alzheimer’s disease,” says Henrik Zetterberg.
The Gothenburg researchers’ pioneering studies have gained wide international recognition since the measurement method they developed was approved as the global reference method.
“This means that the method will be used as the norm for standardizing beta amyloid measurements around the world. With the help of the standard, people who are worried about Alzheimer’s disease can be tested, and get the same results regardless of whether it is done in San Francisco, Sao Paolo, London, Gothenburg or Cape town,” says Kaj Blennow.
“We put a lot of effort into this project and it has been initiated and conducted, and now completed by us at Gothenburg within the framework of a global cooperation project that we head,” says Henrik Zetterberg.
Promising result for drug candidates
This major advance coincides with recent studies that show promising results for different drug candidates that attack Alzheimer’s disease and target beta amyloids.
“These new drugs will likely prove most effective for persons who have just begun to accumulate beta amyloids in their brain. Then a well-proven and standardized method becomes crucial, as it ensures that these people are identified in a diagnostically safe and precise manner,” says Kaj Blennow.
The global reference method is established by the global platform, the Joint Committee for Traceability in Laboratory Medicine (JCTLM), whose goal is to promote and provide guidance on equivalent, internationally recognized and accepted measurements within laboratory medicine. JCTLM is a collaboration between three global, standardizing institutions: The International Committee for Weights and Measures (CIPM), International Federation for Clinical Chemistry and Laboratory Medicine (IFCC), and the International Laboratory Accreditation Cooperation (ILAC).
Henrik Zetterberg, Professor at the Institute of Neuroscience and Physiology, Sahlgrenska Academy
+46 31-343 0142
+46 768-67 26 47
Kaj Blennow, Sahlgrenska Academy at Gothenburg University
+46 31–343 1791
+46 761–073 835
Calle Björned | idw - Informationsdienst Wissenschaft
Tracking movement of immune cells identifies key first steps in inflammatory arthritis
23.01.2017 | Massachusetts General Hospital
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.
According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
24.01.2017 | Earth Sciences
24.01.2017 | Life Sciences
24.01.2017 | Physics and Astronomy